Mer receptor tyrosine kinase is frequently overexpressed in human non-small cell lung cancer, confirming resistance to erlotinib.
about
The Gas6/TAM System and Multiple SclerosisPolo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T790M mutations.Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.Molecular insights of Gas6/TAM in cancer development and therapy.Pharmacological management of relapsed/refractory NSCLC with chemical drugs.Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer.Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicityMET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib.RAS-MAPK reactivation facilitates acquired resistance in FGFR1-amplified lung cancer and underlies a rationale for upfront FGFR-MEK blockade.The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma.
P2860
Q28067131-008E74EF-9C91-45E2-836C-BB1BA98FFBD0Q37565357-8F48156F-BF8F-4A39-888E-3A5C6D23C563Q37702541-33B0C2C5-A2CB-4744-A68A-BD392D4217E1Q37745358-14653A85-A339-4935-AE1B-5ECDF8D25429Q39095285-291D8793-D504-4AA0-8834-7D30CB7FB8EFQ41606248-DFBD18B5-D489-41AD-8EF4-8024CBE505A5Q41940444-953DFCF0-7DA5-4898-A705-A2DF78F258E3Q47547443-335447A3-CDA6-4F28-9A31-D3C6A83398F9Q52589214-E7EE905A-9B55-4C38-A213-59719438626EQ52648382-7337AAFC-2B2D-4EBC-B0D1-EA57F17A515E
P2860
Mer receptor tyrosine kinase is frequently overexpressed in human non-small cell lung cancer, confirming resistance to erlotinib.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Mer receptor tyrosine kinase i ...... rming resistance to erlotinib.
@ast
Mer receptor tyrosine kinase i ...... rming resistance to erlotinib.
@en
type
label
Mer receptor tyrosine kinase i ...... rming resistance to erlotinib.
@ast
Mer receptor tyrosine kinase i ...... rming resistance to erlotinib.
@en
prefLabel
Mer receptor tyrosine kinase i ...... rming resistance to erlotinib.
@ast
Mer receptor tyrosine kinase i ...... rming resistance to erlotinib.
@en
P2093
P2860
P356
P1433
P1476
Mer receptor tyrosine kinase i ...... rming resistance to erlotinib.
@en
P2093
Huafeng Wei
Linxiong Wang
Shengzhi Xie
Xiaoyan Li
P2860
P304
P356
10.18632/ONCOTARGET.3280
P407
P577
2015-04-01T00:00:00Z